FMC (NYSE:FMC) on Wednesday was downgraded to Sector Perform from a previous investment rating of Outperform by analysts at ...

RBC Capital analyst Ashish Sabadra maintained a Buy rating on Moody’s (MCO – Research Report) on February 4 and set a price target of $550.00.

RBC Capital analyst Ashish Sabadra maintained a Buy rating on S&P Global (SPGI – Research Report) on February 4 and set a price target of ...

Amy Wu Silverman, RBC Capital Markets head of derivatives strategy, joins "Squawk Box' to discuss the latest market trends, ...

The stock market extended its winning streak on Wednesday, closing firmer as investors seemed to have already priced in the ...

Find insight on TotalEnergies, oil and natural gas futures, and more in the latest Market Talks covering Energy and Utilities ...

In a recent transaction, Jason Phillips, President of Celestica Inc . (NYSE:CLS), sold 95,979 common shares of the company. The stock has been a stellar performer, surging 289% over the past year to ...

SmartCentres Real Estate Investment Trust ("SmartCentres” or the "Trust”) (TSX:SRU.UN) announced today that it has closed its ...

Oxford, UK - 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the ...

RBC Capital Mkts has recently raised SAGE Therapeutics Inc (SAGE) stock to Sector Perform rating, as announced on November 21, 2024, according to Finviz. Earlier, on October 10, 2 ...

Neumora Therapeutics Inc (NMRA) stock saw a modest uptick, ending the day at $1.91 which represents a slight increase of $0.05 or 2.69% from the prior close of $1.86. The stock opened at $1.87 and ...

Consistent with higher expectations for additional Bank of Canada rate cuts — following six since June, most recently a quarter-point reduction to three per cent on Jan. 29 — Canadian short-term bond ...